Quest Diagnostics Incorporated (DGX)
Days of sales outstanding (DSO)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| DSO | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
Based on the provided data, there is no specific information available regarding Quest Diagnostics Incorporated's days of sales outstanding (DSO) for the specified periods from March 31, 2020, to December 31, 2024.
In financial analysis, DSO is a key efficiency ratio that measures the average number of days it takes a company to collect payment after a sale has been made. A lower DSO indicates that the company is efficient in collecting its accounts receivable, while a higher DSO may suggest potential issues with customer credit or collections processes.
Without the actual DSO figures, it is challenging to assess Quest Diagnostics Incorporated's effectiveness in managing its accounts receivable and cash flow. Tracking the trend of DSO over time would provide insights into the company's credit and collection practices, as well as its overall financial health.
It is recommended to seek additional information or access the company's financial reports to obtain the actual DSO figures for a more in-depth analysis of Quest Diagnostics Incorporated's working capital management and financial performance.
Peer comparison
Dec 31, 2024